This site is part of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
The Fi Europe Conference 2026 delivers two days of future-focused insights for R&D, innovation, and strategy professionals in the food and beverage ingredient space. With expert keynotes, case studies, and panels, we decode the opportunities shaping tomorrow's food systems.
Wellness in 2026 centres on weight management, preventive care, and holistic nutrition. Discover how GLP-1 medications are reshaping consumer expectations and driving demand for nutrient-dense, functional foods that support metabolic health and overall well-being.
Highlights:
The plant-based sector is maturing beyond simple substitutes into ingredient-first solutions. Explore precision fermentation, hybrid blends, and cultivated proteins as the industry balances taste, nutrition, cost, and sustainability through credible science and performance.
Highlights:
Reformulation remains critical as regulators and consumers demand healthier, cleaner foods. With new dietary guidelines and the influence of GLP-1 trends, the industry is pivoting toward nutrient-dense, functional formulations that meet both regulatory targets and evolving consumer preferences.
Highlights:
AI, machine learning, and biotechnology are redefining ingredient development in 2026. From digital formulation screening to wearable-driven nutrition insights, discover how data-driven innovation and smart processing are creating faster, smarter, more sustainable solutions.
Highlights:
Explore how GLP-1 medications and nutrient-stimulated hormone therapies are transforming food innovation. Learn how the industry is adapting to consumers eating less but expecting more—through nutrient density, satiety-led design, and functional formats that deliver measurable health outcomes.
Highlights:
Weight management is reshaping the food and beverage industry—shifting focus from calorie restriction to nutrient density, metabolic health, and functional eating.
As GLP-1 medications and nutrient-stimulated hormone therapies (NuSHs) redefine consumer appetites and expectations, the industry faces a fundamental question: how do we make food work harder nutritionally when consumers are eating less, craving differently, and demanding measurable health outcomes from every bite?
At Fi Europe 2026, this transformative category takes centre stage. Bringing together science, innovation, and industry expertise, this is your hub for exploring the future of food in a lower-intake, higher-functionality world.
Discover how GLP-1 trends are creating new opportunities for nutrient-dense formulations, satiety-led design, and therapeutic food formats that meet evolving consumer needs.
Meet leading experts, ingredient suppliers, and brands to explore evidence-based reformulation strategies, functional ingredients, and emerging research on appetite modulation and metabolic health..
Learn what today's consumers expect—from high-protein, high-fibre solutions to convenient meal replacements and "everyday therapeutic" formats designed for smaller portions and greater nutritional impact.
Network with stakeholders from R&D, nutrition science, regulatory, retail, and brand strategy to navigate the commercial and scientific challenges of this new era in food innovation.
Be amongst the future tastemakers.
Shape tomorrow's tastes.
Visas, hotels, food and more.